A distinct mechanism for galectin-1-mediated immunosuppression was proposed by Rubinstein et al., whereby tumor secreted galectin-1 impairs T cell effector functions involved in eradicating cancer cells from a host [122]. Here, LGALS1 is linked to neoplasm.